PPARGC1A and Alzheimer disease: Since PGC-1α signaling is present in neurons and PGC-1α levels are reduced in the AD brain, where its protein levels are negatively correlated with amyloid pathology [10, 77], suggesting a possible new avenue for exploring pathological dysregulation of the immunometabolic connection in AD.